Nuvation Bio Inc (NYSE: NUVB) stock fell 13% after receiving FDA approval for its lung cancer drug IBTROZI, compared to a 1% decline in the XBI biotech index. The approval, which came ahead of ...

Vijay Pande, a general partner at Andreessen Horowitz who founded the firm’s a16z Bio + Health strategy, announced that he is stepping down from his role. Since its founding in 2014, a16z Bio ...

Fingerprint-based drug tests now used at 20+ Managed Waste Service sites in New South Wales. Results from Intelligent Bio’s system delivered in under 10 minutes on-site. From tariffs to ...

Climb Bio (NASDAQ:CLYM) has announced the appointments of Edgar D. Charles as its Chief Medical Officer (CMO) and Cindy J. Driscoll, as Senior Vice President, Finance.

WELLESLEY HILLS, Mass. - Climb Bio, Inc. (NASDAQ:CLYM), a clinical-stage biotechnology company with a market capitalization of $81 million, has appointed Edgar D. Charles, M.D., MSc as Chief ...

Learn the pros and cons of biodiesel vs. diesel, what's driving the market, and why you might want to consider making the transition to biodiesel yourself.

PHILADELPHIA, June 11, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (“Cabaletta” or the “Company”) (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and ...

Federal judge releases Kseniia Petrova, a Russian-born cancer researcher accused of smuggling frog embryo samples, while limiting her travel and maintaining custody of her passport.

Climb Bio (CLYM) has announced the appointments of Edgar D. Charles as its Chief Medical Officer ( (CMO)) and Cindy J. Driscoll, as Senior Vice President, Finance. Charles most recently served as ...

Climb Bio anticipates that subsequent events and developments will cause Climb Bio's views to change. However, while Climb Bio may elect to update these forward-looking statements at some point in the ...